BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 10/03/2026

FDA Releases Revised Draft Guidance on Biosimilar Development and BPCI Act

The FDA has released a revised draft guidance for industry on biosimilar development and the Biologics Price Competition and Innovation Act, replacing the previous version issued in 2021.

Source: Federal Register — Food and Drug AdministrationOpen original release →